Ardsley Advisory Partners’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-20,000
| Closed | -$102K | – | 171 |
|
|
2019
Q3 | $102K | Hold |
20,000
| – | – | 0.02% | 102 |
|
|
2019
Q2 | $143K | Sell |
20,000
-21,000
| -51% | -$150K | 0.02% | 118 |
|
|
2019
Q1 | $544K | Buy |
41,000
+1,000
| +3% | +$13.3K | 0.1% | 67 |
|
|
2018
Q4 | $315K | Sell |
40,000
-10,000
| -20% | -$78.8K | 0.08% | 75 |
|
|
2018
Q3 | $554K | Hold |
50,000
| – | – | 0.07% | 85 |
|
|
2018
Q2 | $671K | Sell |
50,000
-25,000
| -33% | -$336K | 0.1% | 80 |
|
|
2018
Q1 | $975K | Sell |
75,000
-425,000
| -85% | -$5.53M | 0.15% | 62 |
|
|
2017
Q4 | $4.6M | Buy |
500,000
+429,790
| +612% | +$3.95M | 0.56% | 37 |
|
|
2017
Q3 | $566K | Buy |
70,210
+20,000
| +40% | +$161K | 0.08% | 80 |
|
|
2017
Q2 | $290K | Buy |
50,210
+20,000
| +66% | +$116K | 0.05% | 99 |
|
|
2017
Q1 | $130K | Buy |
30,210
+15,000
| +99% | +$64.5K | 0.02% | 121 |
|
|
2016
Q4 | $26K | Buy |
+15,210
| New | +$26K | ﹤0.01% | 112 |
|